|
US2018110737A1
|
|
Extended-release oral pharmaceutical composition of amphetamine
|
|
US2016263152A1
|
|
Bowel cleansing composition with improved taste
|
|
US2017290740A1
|
|
Colonoscopy prep bag and methods of use
|
|
US2016263065A1
|
|
Topical pharmaceutical gel composition of diclofenac sodium
|
|
US2016263029A1
|
|
Topical pharmaceutical gel composition of diclofenac sodium
|
|
US2016243064A1
|
|
Novel oral pharmaceutical compositions of treprostinil
|
|
US2016376245A1
|
|
Impurity of famotidine
|
|
US2017105930A1
|
|
Aqueous ophthalmic solution of olopatadine
|
|
US2016338951A1
|
|
Process of preparing aqueous ophthalmic solution of olopatadine
|
|
US2016303155A1
|
|
Topical Solution Composition Comprising Ivermectin
|
|
US2016303151A1
|
|
Topical Composition of Ivermectin
|
|
US2016303154A1
|
|
Topical Gel Composition Comprising Ivermectin
|
|
US2016303153A1
|
|
Topical Lotion Composition Comprising Ivermectin
|
|
US2016303152A1
|
|
Topical Composition of Ivermectin
|
|
US2016271121A1
|
|
Antifungal combination therapy
|
|
US2016271060A1
|
|
Ophthalmic emulsion composition of cyclosporine
|
|
US2016271058A1
|
|
Ophthalmic emulsion composition of cyclosporine
|
|
US2016271059A1
|
|
Ophthalmic emulsion composition of cyclosporine
|
|
US2016263102A1
|
|
Pharmaceutical composition of bupropion and naltrexone
|
|
US2016220561A1
|
|
Pharmaceutical composition of bupropion and naltrexone
|
